Results 91 to 100 of about 476,712 (311)

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

open access: yesMolecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo   +8 more
wiley   +1 more source

A Singing Bone from the Mätäjärvi (‘Rotten Lake’) Quarter of Medieval Turku, Finland: Experimental Reconstructions and Contemporary Musical Exploration

open access: yesEXARC Journal, 2021
At the turn of the 14th and 15th centuries, in the town of Turku (SW Finland), a new quarter was built near a lake that came to be known as Mätäjärvi (‘Rotten Lake’), possibly because it was polluted by the waste from leather tanners, shoemakers, and ...
Riitta Rainio   +2 more
doaj  

Novel Sources of Biodiversity and Biomolecules from Bacteria Isolated from a High Middle Ages Soil Sample in Palermo (Sicily, Italy). [PDF]

open access: yesMicrobiol Spectr, 2023
Vassallo A   +20 more
europepmc   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

open access: yesMolecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song   +11 more
wiley   +1 more source

Walruses on the Dnieper: new evidence for the intercontinental trade of Greenlandic ivory in the Middle Ages. [PDF]

open access: yesProc Biol Sci, 2022
Barrett JH   +7 more
europepmc   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

A pan-European art trade in the late middle ages: Isotopic evidence on the master of Rimini enigma. [PDF]

open access: yesPLoS One, 2022
Kloppmann W   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy